by Eileen Petridis, The North American Menopause Society menopauseCredit: Pixabay/CC0 Public DomainHormone therapy (HT) is already recognized as the most effective treatment option for physiologic menopause symptoms such as hot flashes, but a new study is one of the first to suggest that it might also help manage depressive symptoms. It further documented a high...
by Justin Jackson , Medical Xpress Credit: CC0 Public Domain Researchers at the University of Texas Medical Branch, Galveston, have provided substantial evidence supporting the potential role of statins in mitigating venous thromboembolism (VTE) risk associated with hormone therapy in postmenopausal women, possibly reshaping the risk-benefit considerations for this population. In a paper, “Statin Use...
by Canadian Medical Association Journal Credit: Pixabay/CC0 Public Domain Hot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity. A new review published in the Canadian Medical Association Journal (CMAJ ) recommends menopausal hormone therapy, historically known as hormone replacement therapy (HRT), as first-line treatment in people without risk factors....
by The North American Menopause Society Credit: Unsplash/CC0 Public Domain Women aged 40 to 60 years are most affected by adhesive capsulitis, a painful orthopedic disorder characterized by sudden shoulder pain and loss of range of motion. There has been limited research around the disorder’s predilection for perimenopausal women, but a new study found that...
by American Society of Nephrology (ASN) Graphical abstract. Credit: Clinical Journal of the American Society of Nephrology (2022). DOI: 10.2215/CJN.01890222 Gender-affirming hormone therapy modifies body composition and lean muscle mass in transgender persons. A recent analysis published in the Clinical Journal of the American Society of Nephrology examined the effects of masculinizing and feminizing gender-affirming hormone therapy on markers...
TAYLOR & FRANCIS GROUP Hormone therapy for prostate cancer increases the risk of cardiovascular disease-related death especially in older men, according to a population study involving more than 13,000 patients. The paper, published today in the peer-reviewed journal. The Aging Male, found an elevated risk of death from cardiovascular disease for men with prostate cancer...
Miriam E. Tucker, for Medscape July 01, 2022 Researchers published the study covered in this summary on medRxiv.org as a preprint that has not yet been peer reviewed. Key Takeaways Estrogen therapy either by itself or in combination with progesterone among women aged 65 and older is beneficial and does not necessarily raise mortality or cancer risk. ...
THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS) CLEVELAND, Ohio (July 7, 2022)—In the 20 years since the Women’s Health Initiative, hormone therapy remains one of the most hotly debated topics around the treatment of such bothersome menopause symptoms as hot flashes. In an effort to provide the most up-to-date, scientifically based information on the topic, The...
by Uppsala University Credit: Unsplash/CC0 Public Domain A new study from Uppsala University shows that oral contraceptives and hormone therapy at menopause increase the risk of stroke. The increased risk is greatest during the first year of treatment and then declines. The study, which is now published in Stroke, is based on data from over a quarter...
The U.S. Preventive Services Task Force recommends against use of combined estrogen and progestin and estrogen alone for primary prevention of chronic conditions in postmenopausal persons. These findings form the basis of a draft recommendation statement published online April 19. Gerald Gartlehner, M.D., M.P.H., from the RTI International-University of North Carolina at Chapel Hill Evidence-based...
